Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
1.
Transplant Proc ; 50(10): 3192-3198, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30577184

ABSTRACT

BACKGROUND: The treatment of choice in end-stage renal disease is transplantation. Hemodynamic disturbances can evoke graft loss, while early ultrasound identification of vascular problems improves outcome. The aim of this study was to identify differences in postoperative complications with and without systematic intraoperative Doppler ultrasound use. METHODS: The primary outcome was the postoperative rate of complications and the secondary aim was to find a predictive resistance index cut-off value, which would show where surgical reintervention was necessary. Over a 10-year period, 108 renal transplants were performed from living donors at our institution. In group 1 (n = 67), intraoperative duplex ultrasound and intraparenchymatous resistance index measurements assessed patients, while in group 2 (n = 41), no ultrasound was performed. RESULTS: There were no intergroup differences in the overall postoperative complication rate or in benefit to graft or patient survival with Doppler use. However, significantly more vascular complications (10% vs 0%, P = .02) and more acute rejections (37% vs 10%) occurred in group 2 than in group 1. Therefore, an intraoperative cut-off value of the resistance index 0.5 was proposed to justify immediate surgical revision. CONCLUSIONS: This is the first report demonstrating benefits of systematic intraoperative Doppler ultrasound on postoperative complications in renal transplantation from living donors. Our results support surgical revision with a resistance index <0.5.


Subject(s)
Kidney Transplantation/adverse effects , Postoperative Complications/diagnosis , Ultrasonography, Doppler/methods , Vascular Diseases/diagnosis , Vascular Resistance , Adolescent , Adult , Aged , Child , Child, Preschool , Female , Humans , Kidney Failure, Chronic/surgery , Living Donors , Male , Middle Aged , Vascular Diseases/etiology , Young Adult
2.
Eur Rev Med Pharmacol Sci ; 21(2): 310-312, 2017 01.
Article in English | MEDLINE | ID: mdl-28165556

ABSTRACT

We report the case of a 58-year-old man who presented with thoraco-abdominal pain and right lower limb ischemia due to type B aortic dissection. Moreover, the patient was discovered to have several concomitant aortic arch anomalies (bovine arch, arteria lusoria, and left vertebral artery arising from the aortic arch). Taking into account this complex anatomy, emergent femoral exploration with fenestration and thrombectomy was performed. The blood flow to the right lower limb was restored. A few days later the aortic dissection spread proximally, and the aortic arch dilatation enlarged. Before total arch replacement could be performed, the aorta ruptured and the patient unfortunately died.


Subject(s)
Aortic Aneurysm, Thoracic/physiopathology , Aortic Dissection/physiopathology , Ischemia/physiopathology , Leg/physiopathology , Aorta, Thoracic/pathology , Humans , Male , Middle Aged
4.
J Mal Vasc ; 41(4): 286-9, 2016 Jul.
Article in French | MEDLINE | ID: mdl-27289256

ABSTRACT

Aneurysms of the deep femoral artery, accounting for 5% of all femoral aneurysms, are uncommon. There is a serious risk of rupture. We report the case of an 83-year-old patient with a painless pulsatile mass in the right groin due to an aneurysm of the deep femoral artery. History taking revealed no cardiovascular risk factors and no other aneurysms at other localizations. The etiology remained unclear because no recent history of local trauma or puncture was found. ACT angiography was performed, revealing a true isolated aneurysm of the deep femoral artery with a diameter of 90mm, beginning 1cm after its origin. There were no signs of rupture or distal emboli. Due to unsuitable anatomy for an endovascular approach, the patient underwent open surgery, with exclusion of the aneurysm and interposition of an 8-mm Dacron graft to preserve deep femoral artery flow. Due to their localization, the diagnosis and the management of aneurysms of the deep femoral artery can be difficult. Options are surgical exclusion or an endovascular approach in the absence of symptoms or as a bridging therapy. If possible, blood flow to the distal deep femoral artery should be maintained, the decision depending also on the patency of the superficial femoral artery. In case of large size, aneurysms of the deep femoral artery should be treated without any delay.


Subject(s)
Aneurysm/diagnosis , Femoral Artery , Aged, 80 and over , Aneurysm/surgery , Angiography , Femoral Artery/diagnostic imaging , Femoral Artery/surgery , Humans , Male
5.
Eur J Vasc Endovasc Surg ; 51(5): 733-42, 2016 05.
Article in English | MEDLINE | ID: mdl-27006011

ABSTRACT

OBJECTIVE: To evaluate the impact of different types of hypertension on the development of intimal hyperplasia (IH). METHOD: Genetic, surgical, and pharmacological models of hypertension were used to compare IH formation in a murine model of carotid artery ligation (CAL). CAL was performed in normotensive WT male mice and in three mouse models of hypertension: (1) L-NAME (Nω-nitro-l-arginine-methyl-ester) treatment for 2 weeks prior to CAL to instate renin-independent hypertension; (2) 2K1C (two kidneys, one clip) surgery 1 week prior to CAL to induce renin-dependent hypertension; (3) Cx40-/- mice, a genetic model of renin-dependent hypertension. Mice were sacrificed prior to CAL or 3, 14, or 28 days post CAL. Data collection included tail blood pressure measurements, and morphometric and histological assessment of the ligated carotids. RESULTS: CAL triggered the formation of a VSMC-rich neointima layer after 14-28 days, which was increased in all hypertensive mice. Despite similarly increased blood pressure, L-NAME treated mice displayed more IH than all other hypertensive groups. In addition, L-NAME induced hypertension triggered more cell proliferation and recruitment of CD45 positive inflammatory cells to the ligated vessel wall compared with Cx40-/- or normotensive WT mice. CONCLUSIONS: NO deficiency is a major aspect of vascular inflammation, VSMC proliferation, and IH in hypertensive conditions.


Subject(s)
Carotid Arteries/pathology , Hyperplasia/etiology , Hypertension/complications , Nitric Oxide/deficiency , Animals , Disease Models, Animal , Hyperplasia/pathology , Hypertension/chemically induced , Hypertension/pathology , Male , Mice , Mice, Inbred C57BL , Muscle, Smooth, Vascular/pathology , NG-Nitroarginine Methyl Ester/pharmacology
7.
Rev Med Suisse ; 10(447): 1992-6, 2014 Oct 22.
Article in French | MEDLINE | ID: mdl-25518210

ABSTRACT

Critical limb ischemia is a major public health problem in our western countries due to the epidemia of (diabesity). The outcome of patients suffering from critical limb ischemia reains poor with an amputation free survival rate at one year of about 50%. The treatment should be multidiciplinary and done in emergency in specialized centers to ensure the limb salvage: this management should be centered aroud 3 axis: the screening of the cardiovascular risk factors, the best medical treatment and the invasive approaches. Due to multiple endovascular technical innovations, more frail patients with com plex diseases can be treated with good results. Therefore, the endovascular treatment is essential in the management of such patients by vascular surgeons.


Subject(s)
Ischemia/therapy , Peripheral Vascular Diseases/therapy , Amputation, Surgical , Endovascular Procedures/methods , Humans , Interdisciplinary Communication , Ischemia/pathology , Leg/blood supply , Limb Salvage/methods , Peripheral Vascular Diseases/pathology
8.
Eur J Vasc Endovasc Surg ; 47(2): 124-30, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24309400

ABSTRACT

OBJECTIVES: A straightforward original Chimney Graft (CG) protocol has been developed at our institution in selected cases of juxtarenal aortic aneurysm (JRAA). The aim of this study was to present our clinical experience of consecutive series with use of uncovered self-expanding stent (SES) as "Open Chimney" (OCh) in the endovascular repair (EVAR) of JRAA. METHODS: A standard endograft with suprarenal fixation struts is delivered with its proximal covered edge just below the highest RA in JRAA presenting the ostium of the two renal arteries at a different aortic level and the distance between the highest renal artery and the beginning of the aneurysm (improved landing zone) ≥10 mm. The low-lying renal artery is maintained patent by the OCh graft (standard SES) delivered from left brachial access (6 Fr). All clinical, anatomical, and operative data were prospectively collected and retrieved for the study analysis. RESULTS: From July 2010 to November 2012, OCh EVAR was offered to 22 consecutive patients considered unfit for JRAA open repair. All procedures were technically successful with aneurysm exclusion and patent OCh graft. One small perioperative type Ia endoleak spontaneously disappeared at the 3-month CT control. One patient died because of acute decompensated heart failure. One patient presented a left hemispheric stroke. The median follow-up of 18 months (range 7-35) showed aneurysm exclusion in all patients without type I and III endoleaks, SES stenosis, and/or renal impairment. CONCLUSIONS: OCh-EVAR is a straightforward technique that can be employed in selected cases of JRAA, avoiding the more complex and expensive fenestrated EVAR.


Subject(s)
Aortic Aneurysm, Abdominal/surgery , Blood Vessel Prosthesis Implantation/methods , Endovascular Procedures , Renal Artery/surgery , Aged , Aged, 80 and over , Aortic Aneurysm, Abdominal/diagnostic imaging , Aortic Aneurysm, Abdominal/mortality , Aortography/methods , Blood Vessel Prosthesis , Blood Vessel Prosthesis Implantation/adverse effects , Blood Vessel Prosthesis Implantation/instrumentation , Blood Vessel Prosthesis Implantation/mortality , Endovascular Procedures/adverse effects , Endovascular Procedures/instrumentation , Endovascular Procedures/mortality , Female , Humans , Male , Middle Aged , Prosthesis Design , Renal Artery/diagnostic imaging , Stents , Time Factors , Tomography, X-Ray Computed , Treatment Outcome
9.
Eur J Vasc Endovasc Surg ; 45(1): 46-50, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23131715

ABSTRACT

OBJECTIVES: Long occlusions in calcified crural arteries are a major cause of endovascular technical failure in patients with critical limb ischaemia. Therefore, distal bypasses are mainly performed in patients with heavily calcified arteries and with consequently delicate clamping. A new reverse thermosensitive polymer (RTP) is an alternative option to occlude target vessels. The aim of the study is to report our technical experience with RTP and to assess its safety and efficiency to temporarily occlude small calcified arteries during anastomosis time. METHODS: Between July 2010 and December 2011, we used RTP to occlude crural arteries in 20 consecutive patients with 20 venous distal bypasses. We recorded several operative parameters, such as volume of injected RTP, duration of occlusion and anastomotic time. Quality of occlusion was subjectively evaluated. Routine on-table angiography was performed to search for plug emboli. Primary patency, limb salvage and survival rates were reported at 6 months. RESULTS: In all patients, crural artery occlusion was achieved with the RTP without the use of an adjunct occlusion device. Mean volume of RTP used was 0.3 ml proximally and 0.25 ml distally. Mean duration of occlusion was 14.4 ± 4.5 min, while completion of the distal anastomosis lasted 13.4 ± 4.3 min. Quality of occlusion was judged as excellent in eight cases and good in 12 cases. Residual plugs were observed in two patients and removed with an embolectomy catheter, before we amended the technique for dissolution of RTP. At 6 months, primary patency rate was 75% but limb salvage rate was 87.5%. The 30-day mortality rate was 10%. CONCLUSIONS: This study shows that RTP is safe when properly dissolved and effective to occlude small calcified arteries for completion of distal anastomosis.


Subject(s)
Blood Loss, Surgical/prevention & control , Embolization, Therapeutic/methods , Femoral Artery/surgery , Peripheral Arterial Disease/surgery , Poloxamer/therapeutic use , Vascular Calcification/complications , Vascular Grafting , Aged , Aged, 80 and over , Body Temperature , Constriction , Embolectomy , Embolism/etiology , Embolism/physiopathology , Embolism/therapy , Embolization, Therapeutic/adverse effects , Embolization, Therapeutic/mortality , Female , Femoral Artery/diagnostic imaging , Graft Occlusion, Vascular/etiology , Graft Occlusion, Vascular/physiopathology , Graft Occlusion, Vascular/therapy , Humans , Injections, Intra-Arterial , Limb Salvage , Male , Middle Aged , Peripheral Arterial Disease/complications , Peripheral Arterial Disease/diagnosis , Peripheral Arterial Disease/mortality , Peripheral Arterial Disease/physiopathology , Poloxamer/administration & dosage , Poloxamer/adverse effects , Poloxamer/chemistry , Reoperation , Time Factors , Tomography, X-Ray Computed , Treatment Outcome , Ultrasonography, Doppler, Duplex , Vascular Calcification/diagnosis , Vascular Grafting/adverse effects , Vascular Grafting/mortality , Vascular Patency
10.
Eur J Vasc Endovasc Surg ; 44(4): 417-24, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23017216

ABSTRACT

OBJECTIVES: The purpose of this study was to assess short- and mid-term results of in-situ revascularisation (ISR) using silver-coated Dacron prostheses and bowel repair for management of secondary aorto-enteric fistulae (SAEF). DESIGN: Single-centre retrospective chart review. MATERIAL AND METHODS: This study includes all the patients treated by ISR using silver-coated Dacron for SAEF between 2006 and 2010. Primary end points were mortality and survival rates. Secondary end points were reinfection-free survival and secondary patency rates. RESULTS: Eighteen male patients with SAEF with a median age of 64 years were operated by ISR using silver-coated Dacron during the study period without operative death. The 30-day mortality was 22% and the in-hospital mortality rate was 39%. Indeed, during hospitalisation, a duodenal leak was observed in four patients including three who died. Four others patients died due to multi-system organ failure. Median follow-up was 16 months (range 1-66). The survival rate at 12 months was 55%. One duodenal leak was observed leading to death. The reinfection-free survival and the secondary patency rates at 12 months were 60% and 89%, respectively. CONCLUSION: In-situ revascularisation with silver-coated Dacron provides acceptable results in terms of mortality. This treatment may be useful for simple vascular reconstruction and allow greater attention to bowel repair that is a determinant in short- and mid-term survival.


Subject(s)
Aortic Diseases/surgery , Coated Materials, Biocompatible , Duodenal Diseases/surgery , Intestinal Fistula/surgery , Ischemia/surgery , Leg/blood supply , Vascular Fistula/surgery , Aged , Anastomosis, Surgical , Aorta, Abdominal/surgery , Aortic Diseases/complications , Aortic Diseases/diagnostic imaging , Blood Vessel Prosthesis , Duodenal Diseases/complications , Duodenal Diseases/diagnostic imaging , Duodenum/surgery , Follow-Up Studies , Humans , Intestinal Fistula/complications , Intestinal Fistula/diagnostic imaging , Ischemia/diagnostic imaging , Ischemia/etiology , Male , Middle Aged , Polyethylene Terephthalates , Prosthesis Design , Retrospective Studies , Silver , Tomography, X-Ray Computed , Treatment Outcome , Vascular Fistula/complications , Vascular Fistula/diagnostic imaging
11.
Rev Med Suisse ; 8(346): 1332-6, 2012 Jun 20.
Article in French | MEDLINE | ID: mdl-22792598

ABSTRACT

Open surgery is still the main treatment of complex abdominal aortic aneurysm. Nevertheless, this approach is associated with major complications and high mortality rate. Therefore the fenestrated endograft has been used to treat the juxtarenal aneurysms. Unfortunately, no randomised controlled study is available to assess the efficacy of such devices. Moreover, the costs are still prohibitive to generalise this approach. Alternative treatments such as chimney or sandwich technique are being evaluated in order to avoid theses disadvantages. The aim of this paper is to present the endovascular approach to treat juxtarenal aneurysm and to emphasize that this option should be used only by highly specialized vascular centres.


Subject(s)
Abdomen/surgery , Aortic Aneurysm, Abdominal/surgery , Blood Vessel Prosthesis Implantation/trends , Endovascular Procedures/trends , Aortic Aneurysm, Abdominal/complications , Aortic Aneurysm, Abdominal/diagnosis , Blood Vessel Prosthesis/statistics & numerical data , Blood Vessel Prosthesis Implantation/adverse effects , Blood Vessel Prosthesis Implantation/methods , Choice Behavior/physiology , Endovascular Procedures/adverse effects , Endovascular Procedures/methods , Endovascular Procedures/statistics & numerical data , Humans , Models, Biological , Postoperative Complications/etiology , Risk Factors
12.
Eur J Vasc Endovasc Surg ; 43(1): 48-53, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21893420

ABSTRACT

OBJECTIVES: Determine if arm veins are good conduits for infrainguinal revascularisation and should be used when good quality saphenous vein is not available. DESIGN: Retrospective study. MATERIALS AND METHODS: We evaluated a consecutive series of infrainguinal bypass (IB) using arm vein conduits from March 2001 to December 2006.We selected arm vein by preoperative ultrasound mapping to identify suitable veins. We measured vein diameter and assessed vein wall quality. We followed patients with systematic duplex imaging at 1 week, 1, 3, 6 and 12 months, and annually thereafter. We treated significative stenoses found during the follow-up. RESULTS: We performed 56 infrainguinal revascularisation using arm vein conduits in 56 patients. Primary patency rates at 1, 2 and 3 years were 65%, 51% and 47%. Primary assisted patencies at 1, 2 and 3 years were 96%, 96% and 82%. Secondary patency rates at 1, 2 and 3 years were 92%, 88% and 88%. The three-year limb salvage rate was 88%. CONCLUSIONS: We conclude that infrainguinal bypass using arm vein for conduits gives good patency rates, if selected by a preoperative US mapping to use the best autogenous conduit available.


Subject(s)
Lower Extremity/blood supply , Peripheral Arterial Disease/surgery , Upper Extremity/blood supply , Vascular Grafting , Veins/transplantation , Aged , Aged, 80 and over , Female , Humans , Limb Salvage , Male , Middle Aged , Peripheral Arterial Disease/physiopathology , Reoperation , Retrospective Studies , Risk Assessment , Risk Factors , Switzerland , Time Factors , Treatment Outcome , Ultrasonography, Doppler, Duplex , Vascular Grafting/adverse effects , Vascular Patency , Veins/diagnostic imaging
13.
Eur J Vasc Endovasc Surg ; 43(1): 38-42, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22001148

ABSTRACT

OBJECTIVES: The study aims to assess the feasibility and midterm outcome of trans-peritoneal laparoscopy for coeliac artery compression syndrome (CACS). DESIGN: Retrospective chart review involving four European vascular surgery departments and two surgical teams. MATERIALS AND METHODS: charts for patients who underwent laparoscopy for symptomatic CACS between December 2003 and November 2009 were reviewed. Preoperative computed tomography (CT) angiography and postoperative duplex scan and/or CT angiography were performed. RESULTS: Eleven consecutive patients (nine women) with a median age of 52 years (interquartile range: 42.5-59 years) underwent trans-peritoneal laparoscopy for CACS. All patients had a history of postprandial abdominal pain; weight loss exceeded 10% of the body mass in eight cases. Preoperative CT angiography revealed coeliac trunk stenosis >70% in all cases. One patient had additional aortitis and inferior mesenteric artery occlusion, while another patient presented with an occluded superior mesenteric artery. Two conversions occurred (one difficult dissection and one aorto-hepatic bypass needed for incomplete release of CACS). The median blood loss was 195 ml (range: 50-900 ml) and median operative time was 80 min (interquartile range: 65-162.5 years). Symptoms improved immediately in 10/11 patients (no residual stenosis) while one remained unchanged despite a residual stenosis treated by a percutaneous angioplasty. Symptoms reappeared in one patient due to coeliac axis occlusion. The mean follow-up period was 35 ± 23 months (range: 12-78 months). CONCLUSION: Our study demonstrates that trans-peritoneal laparoscopy for treating median arcuate ligament syndrome is safe and feasible. Additional patients and a longer follow-up are needed for long-term assessment of this laparoscopic technique.


Subject(s)
Arterial Occlusive Diseases/surgery , Celiac Artery , Decompression, Surgical/methods , Laparoscopy , Adult , Aged , Arterial Occlusive Diseases/diagnosis , Arterial Occlusive Diseases/etiology , Celiac Artery/diagnostic imaging , Constriction, Pathologic , Decompression, Surgical/adverse effects , Europe , Feasibility Studies , Female , Humans , Laparoscopy/adverse effects , Ligaments/surgery , Male , Middle Aged , Retrospective Studies , Time Factors , Tomography, X-Ray Computed , Treatment Outcome , Ultrasonography, Doppler, Duplex
14.
Eur Surg Res ; 45(1): 50-9, 2010.
Article in English | MEDLINE | ID: mdl-20798546

ABSTRACT

Vessel wall trauma induces vascular remodeling processes including the development of intimal hyperplasia (IH). To assess the development of IH in human veins, we have used an ex vivo vein support system (EVVSS) allowing the perfusion of freshly isolated segments of saphenous veins in the presence of a pulsatile flow which reproduced arterial conditions regarding shear stress, flow rate and pressure during a period of 7 and 14 days. Compared to the corresponding freshly harvested human veins, histomorphometric analysis showed a significant increase in the intimal thickness which was already maximal after 7 days of perfusion. Expression of the endothelial marker CD31 demonstrated the presence of endothelium up to 14 days of perfusion. In our EVVSS model, the activity as well as the mRNA and protein expression levels of plasminogen activator inhibitor 1, the inhibitor of urokinase-type plasminogen activator (uPA) and tissue-type plasminogen activator (tPA), were increased after 7 days of perfusion, whereas the expression levels of tPA and uPA were not altered. No major change was observed between 7 and 14 days of perfusion. These data show that our newly developed EVVSS is a valuable setting to study ex vivo remodeling of human veins submitted to a pulsatile flow.


Subject(s)
Saphenous Vein/physiology , Aged , Blood Flow Velocity , Cell Culture Techniques/methods , Endothelium, Vascular/physiology , Female , Humans , Male , Perfusion/methods , Plasminogen Activator Inhibitor 1/genetics , Platelet Endothelial Cell Adhesion Molecule-1/immunology , Pulse , Saphenous Vein/cytology , Saphenous Vein/immunology , Saphenous Vein/pathology , Tissue Plasminogen Activator/genetics , Tissue and Organ Harvesting/methods , Tunica Media/pathology , Urokinase-Type Plasminogen Activator/genetics , Vascular Surgical Procedures
SELECTION OF CITATIONS
SEARCH DETAIL
...